Welcome to LookChem.com Sign In|Join Free

CAS

  • or

24143-17-7

Post Buying Request

24143-17-7 Suppliers

Recommended suppliersmore

This product is a nationally controlled contraband, and the Lookchem platform doesn't provide relevant sales information.

24143-17-7 Usage

Description

OXAZOLAM METHANOL SOLUTION is a psychotropic agent that possesses anxiolytic, anticonvulsant, sedative, and skeletal muscle relaxant properties. It serves as a precursor to the active substance Desmethyldiazepam (D291595), making it a valuable compound in the pharmaceutical industry.

Uses

Used in Pharmaceutical Industry:
OXAZOLAM METHANOL SOLUTION is used as a psychotropic agent for its anxiolytic, anticonvulsant, sedative, and skeletal muscle relaxant properties. It helps in the treatment of anxiety disorders, seizures, and muscle spasms, providing relief to patients suffering from these conditions.
Additionally, OXAZOLAM METHANOL SOLUTION is used as a precursor to the active substance Desmethyldiazepam (D291595), which further enhances its importance in the development of new medications and therapies in the pharmaceutical sector.

Originator

Serenal,Sankyo,Japan,1970

Manufacturing Process

To a solution of 12.0 g of 5-chloro-2-chloroacetylaminobenzophenone and 3.2 g of isopropanolamine in 100 ml of ethanol was added 3.3 g of sodium acetate. The resulting mixture was heated under reflux with stirring for 12 hours. After completion of the reaction, the solvent was distilled off and the residue was extracted with dichloromethane. The extract was washed with water, dried over anhydrous sodium sulfate and the solvent was distilled off. The residue was recrystallized from ethanol to give 10.6 g of the desired product melting at 186°C to 188.5°C.

Therapeutic Function

Tranquilizer

Safety Profile

Moderately toxic by intraperitoneal route. Mildly toxic by ingestion.An experimental teratogen. Experimental reproductive effects. When heated to decomposition it emits toxic fumes of Clí and NOx.

Check Digit Verification of cas no

The CAS Registry Mumber 24143-17-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,4,1,4 and 3 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 24143-17:
(7*2)+(6*4)+(5*1)+(4*4)+(3*3)+(2*1)+(1*7)=77
77 % 10 = 7
So 24143-17-7 is a valid CAS Registry Number.
InChI:InChI=1/C18H17ClN2O2/c1-12-10-21-11-17(22)20-16-8-7-14(19)9-15(16)18(21,23-12)13-5-3-2-4-6-13/h2-9,12H,10-11H2,1H3,(H,20,22)/t12-,18+/m1/s1

24143-17-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name (2R,11bS)-10-chloro-2-methyl-11b-phenyl-2,3,5,7-tetrahydro-[1,3]oxazolo[3,2-d][1,4]benzodiazepin-6-one

1.2 Other means of identification

Product number -
Other names DEA No. 2839

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:24143-17-7 SDS

24143-17-7Downstream Products

24143-17-7Relevant articles and documents

cis/trans Isomerization rate of oxazolam in organic solvents measured by high-performance liquid chromatography

Kurono,Jinno,Kuwayama,Sato,Yashiro,Ikeda

, p. 1044 - 1046 (2007/10/02)

-

Intermediates for tricyclic benzodiazepines

-

, (2008/06/13)

Tricyclic benzodiazepine derivatives ("A") bearing a hydroxylower alkyl substituent in the 1-position and a heterocyclic ring joined between positions 4 and 5 of the benzodiazepine moiety are described. The heterocyclic ring will contain the nitrogen atom appearing at position 4 of the benzodiazepine ring as well as the hetero atom, which may be either oxygen or nitrogen, attached to the carbon atom at the 5-position of the benzodiazepine ring. "A" bearing an oxygen atom in the new heterocyclic ring may be formed from the corresponding 4,5-unsaturated benzodiazepines by treatment with an epoxide compound in the presence of an acid catalyst. "A" bearing either a nitrogen or an oxygen atom in the new heterocyclic ring may be prepared by cyclization of the corresponding open compound. "A" are useful as sedative, muscle relaxant and anti-convulsant agents.